2021 Updates in Hematologic Malignancies



This one-day CME activity features leading experts in the field, comprehensive clinical content, and the opportunity to interact with colleagues. Participation in this conference will provide learners an opportunity to hear experts perspectives on translation of emerging and practice changing findings into novel treatment strategies, personalized care according to patient and tumor characteristics, proactive mitigation and management of treatment-related toxicities, and opportunity to answer challenging patient care questions during case-based discussion sessions. The goal of this activity is to improve the knowledge, competence and performance of participants learning evidence-based management of hematologic malignancies.

On the agenda:

  • Update on the management of low-grade lymphomas
  • Management of aggressive lymphoma in the era of CAR T-cells
  • Chronic lymphocytic leukemia
  • Acute myeloid leukemia
  • Acute lymphoblastic leukemia
  • Front line therapy for newly diagnosed multiple myeloma
  • Treatment of relapse/refractory multiple myeloma
  • Treatment free remission in chronic myeloid leukemia
  • Management of Non-CML myeloproliferative neoplasms (MPNs) in 2021
  6.5 AMA PRA Category 1 Credits™ - maximum

6.5 CNE contact hours

6.5 ABIM MOC points

Venue: Hilton Salt Lake City Center


October 2, 2021


Salt Lake City, Utah 84101, United States